Summary of Prognostic Factors and Patient Selection for Extrapleural Pneumonectomy in the Treatment of Malignant Pleural Mesothelioma

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Annals of Surgical Oncology

• Publication date

  2011-04-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1245/s10434-011-1728-xPMID 21512863
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Surgery for mesothelioma: MARS landing and future missions.

  2010cited by this paper
• Characteristics of malignant pleural mesothelioma in women.

  2010cited by this paper
• Therapeutic surgery for nonepithelioid malignant pleural mesothelioma: is it really worthwhile?

  2010cited by this paper
• Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma.

  2009cited by this paper
• Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma

  2009cited by this paper
• Is malignant pleural mesothelioma a surgical disease? A review of 83 consecutive extra-pleural pneumonectomies.

  2009cited by this paper
• Trimodality therapy for malignant pleural mesothelioma.

  2009cited by this paper
• Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors.

  2009cited by this paper
• Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study.

  2009cited by this paper
• A phase I study of extrapleural pneumonectomy and intracavitary intraoperative hyperthermic cisplatin with amifostine cytoprotection for malignant pleural mesothelioma.

  2009cited by this paper
• Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.

  2009cited by this paper
• The value of occult disease in resection margin and lymph node after extrapleural pneumonectomy for malignant mesothelioma.

  2008cited by this paper
• Outcome after extrapleural pneumonectomy for malignant pleural mesothelioma.

  2008cited by this paper
• The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: implications for revision of the American Joint Committee on Cancer staging system.

  2008cited by this paper
• Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.

  2008cited by this paper
• Right extrapleural pneumonectomy for malignant mesothelioma via median sternotomy or thoracotomy? Short- and long-term results.

  2007cited by this paper
• Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma.

  2007cited by this paper
• Mesothelioma: benefit from surgical resection is questionable.

  2007cited by this paper
• Ten traps for the unwary in surgical series: a case study in mesothelioma reports.

  2007cited by this paper
• Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma.

  2007cited by this paper
• Pathology and genetics of tumours of the lung , pleura, thymus and heart

  2004cited by this paper
• The management of malignant pleural mesothelioma.

  2003cited by this paper
• The management of malignant pleural mesothelioma; single centre experience in 10 years.

  2002cited by this paper
• A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.

  2001cited by this paper
• Intraoperative photodynamic therapy after pleuropneumonectomy in patients with malignant pleural mesothelioma: dose finding and toxicity results.

  2001cited by this paper
• Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.

  1999cited by this paper
• Indications for pneumonectomy. Extrapleural pneumonectomy.

  1999cited by this paper
• The European mesothelioma epidemic

  1999cited by this paper
• Preoperative tumor volume is associated with outcome in malignant pleural mesothelioma.

  1998cited by this paper
• Analysis of current trends in United States mesothelioma incidence.

  1997cited by this paper
• A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group.

  1995cited by this paper
• Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma.

  1993cited by this paper
• Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients.

  1976cited by this paper
• [Indications for pneumonectomy].

  1948cited by this paper

• Efficacy of cryobiopsy during medical thoracoscopy for diagnosing malignant pleural mesothelioma.

  2024cites this paper
• Survival Effect of Complete Multimodal Therapy in Malignant Pleural Mesothelioma

  2022cites this paper
• Landmark Trials in the Surgical Management of Mesothelioma

  2021cites this paper
• Emerging therapies in malignant pleural mesothelioma.

  2019cites this paper
• Pleural thickness after neoadjuvant chemotherapy is a prognostic factor in malignant pleural mesothelioma

  2019cites this paper
• Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline.

  2018cites this paper
• Malignant Pleural Mesothelioma

  2017cites this paper
• Malignant mesothelioma in Australia 2015: Current incidence and asbestos exposure trends

  2016cites this paper
• The role of thoracic surgery in the management of mesothelioma: an expert opinion on the limited evidence

  2016cites this paper
• Advance Australasia Fair: A quarter of a century of contributions to cardiothoracic surgical science?

  2016cites this paper
• Management of malignant pleural mesothelioma—part 2: therapeutic approaches

  2016cites this paper
• Management of malignant pleural mesothelioma – part 3

  2016cites this paper
• Patterns in the incidence, mortality and survival of malignant pleural and peritoneal mesothelioma, New South Wales, 1972–2009

  2016cites this paper
• Modern management of malignant pleural mesothelioma

  2016influential citation
• The role of endobronchial ultrasound‐guided fine needle aspiration in the diagnosis of pleural mesothelioma

  2016cites this paper
• Surgical Management of Malignant Pleural Mesothelioma: An Update of Clinical Evidence.

  2015cites this paper
• A New Prognostic Score Supporting Treatment Allocation for Multimodality Therapy for Malignant Pleural Mesothelioma: A Review of 12 Years’ Experience

  2015cites this paper
• A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma.

  2014cites this paper
• Naftopidil Is Useful for the Treatment of Malignant Pleural Mesothelioma

  2014cites this paper
• Surgical and Medical Therapy for Malignant Pleural Mesothelioma

  2014cites this paper
• Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma

  2014cites this paper
• "Lower door open thoracotomy": a feasible approach for extra-pleural pneumonectomy.

  2013influential citation
• Excision repair cross complementation group 1 and thymidylate synthase expression in patients with mesothelioma.

  2013cites this paper
• EphB4 as a therapeutic target in mesothelioma

  2013cites this paper
• The application of cold-plasma coagulation on the visceral pleura results in a predictable depth of necrosis without fistula generation.

  2012cites this paper
• Pretreatment Serum C-Reactive Protein Levels Predict Benefit From Multimodality Treatment Including Radical Surgery in Malignant Pleural Mesothelioma: A Retrospective Multicenter Analysis

  2012cites this paper
• Systemic treatment of malignant pleural mesothelioma.

  2012cites this paper
• Mesotelioma pleural maligno Malignant Pleural Mesothelioma

  2012cites this paper
• Clinical and biologic prognostic factors in malignant pleural mesothelioma

  2012cites this paper
• Malignant pleural mesothelioma: factors influencing the prognosis.

  2012influential citation
• Systematic review of trimodality therapy for patients with malignant pleural mesothelioma.

  2012cites this paper
• Mesothelioma: an update

  2011cites this paper